Table 1. Sequence-dependent effects of... | American Society of Hematology

Table 1.

Sequence-dependent effects of ATRA/FK228 on cytotoxicity of DOX in NB4 cells

	CI
	ATRA/FK228 followed by DOX					ATRA/FK228/DOX				DOX followed by ATRA/FK228
	ED₅₀	ED₇₅	ED₉₀	ED₅₀	ED₇₅	ED₉₀	ED₅₀	ED₇₅	ED₉₀
Trypan blue-positive cells, %	3.81	5.47	10.80	1.34	0.77	0.60	0.99	0.71	0.71
Annexin V-positive cells, %	2.07	2.40	2.94	0.68	0.52	0.42	0.97	1.08	1.27

	CI
	ATRA/FK228 followed by DOX					ATRA/FK228/DOX				DOX followed by ATRA/FK228
	ED₅₀	ED₇₅	ED₉₀	ED₅₀	ED₇₅	ED₉₀	ED₅₀	ED₇₅	ED₉₀
Trypan blue-positive cells, %	3.81	5.47	10.80	1.34	0.77	0.60	0.99	0.71	0.71
Annexin V-positive cells, %	2.07	2.40	2.94	0.68	0.52	0.42	0.97	1.08	1.27

ATRA (0.125, 0.25, and 0.5 mM) and FK228 (1.0, 2.0, and 3.0 nM) were given at a fixed ratio either 24 hours prior to DOX (8.5, 17.0, and 34.0 nM) treatment, simultaneously with DOX, or 24 hours after initiation of DOX treatment. Total time of DOX exposure was 72 hours in all experiments. Effects on cytotoxicity were determined by annexin V flow cytometry and by cell counts using trypan blue exclusion test. Numbers represent CI values obtained at the ED₅₀, ED₇₅, and ED₉₀. ED₅₀ indicates 50% effective dose.

View Large

This Feature Is Available To Subscribers Only